$KOSS
KOSS CORP

2023 Q3 Form 10-K Financial Statement

#000005670123000026 Filed on August 25, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2023
Revenue $3.374M $3.104M $13.10M
YoY Change 0.58% -25.95% -25.6%
Cost Of Revenue $2.306M $2.252M $8.642M
YoY Change 6.36% -15.64% -21.36%
Gross Profit $1.068M $852.4K $4.457M
YoY Change -9.99% -44.02% -32.64%
Gross Profit Margin 31.65% 27.46% 34.03%
Selling, General & Admin $1.536M $1.468M $29.36M
YoY Change -93.51% 28.89% 413.68%
% of Gross Profit 143.89% 172.21% 658.64%
Research & Development $288.2K
YoY Change 1.05%
% of Gross Profit 6.47%
Depreciation & Amortization $45.61K $44.12K $230.3K
YoY Change -32.53% -35.44% -21.53%
% of Gross Profit 4.27% 5.18% 5.17%
Operating Expenses $1.536M $1.468M $29.65M
YoY Change -93.51% 28.89% 394.06%
Operating Profit -$468.6K -$615.5K -$24.90M
YoY Change -97.92% -260.37% -2860.58%
Interest Expense $212.9K $206.3K $520.8K
YoY Change 686.73% 5506.79% 4423.66%
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00 $33.00M
YoY Change -100.0% 9006.21%
Pretax Income -$255.7K -$409.2K $8.620M
YoY Change -102.43% -205.6% 575.57%
Income Tax $1.879K -$146.6K $317.4K
% Of Pretax Income 3.68%
Net Earnings -$257.6K -$262.6K $8.302M
YoY Change -102.59% -168.11% 554.55%
Net Earnings / Revenue -7.64% -8.46% 63.38%
Basic Earnings Per Share -$0.03 $0.90
Diluted Earnings Per Share -$0.03 -$0.03 $0.85
COMMON SHARES
Basic Shares Outstanding 9.235M 9.217M 9.193M
Diluted Shares Outstanding 9.235M 9.754M

Balance Sheet

Concept 2023 Q3 2023 Q2 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $19.17M $20.16M $20.16M
YoY Change -8.15% 118.89% 118.89%
Cash & Equivalents $1.984M $3.091M $3.091M
Short-Term Investments $17.18M $17.06M $17.06M
Other Short-Term Assets $460.0K $284.6K $284.6K
YoY Change 15.44% 51.01% 51.01%
Inventory $5.779M $6.423M $6.423M
Prepaid Expenses
Receivables $1.331M $1.380M $1.380M
Other Receivables $180.0K $138.1K $138.1K
Total Short-Term Assets $26.92M $28.38M $28.38M
YoY Change -12.98% 42.8% 42.8%
LONG-TERM ASSETS
Property, Plant & Equipment $1.221M $953.9K $3.970M
YoY Change 18.29% -12.33% -8.44%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $9.194M $9.036M $6.020M
YoY Change 0.33% 0.48% 4.79%
Total Long-Term Assets $10.41M $9.990M $9.990M
YoY Change 2.14% -0.9% -0.9%
TOTAL ASSETS
Total Short-Term Assets $26.92M $28.38M $28.38M
Total Long-Term Assets $10.41M $9.990M $9.990M
Total Assets $37.34M $38.37M $38.37M
YoY Change -9.23% 28.09% 28.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $228.5K $267.5K $267.5K
YoY Change -56.17% -66.4% -66.4%
Accrued Expenses $498.2K $970.5K $1.207M
YoY Change -67.11% 73.2% 53.95%
Deferred Revenue $352.7K $450.3K
YoY Change -10.3% -17.21%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.312M $2.012M $2.012M
YoY Change -59.73% -5.41% -5.41%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $4.780M $4.898M $4.898M
YoY Change -5.89% -4.53% -4.53%
Total Long-Term Liabilities $4.777M $4.898M $4.898M
YoY Change -5.94% -4.53% -4.53%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.312M $2.012M $2.012M
Total Long-Term Liabilities $4.777M $4.898M $4.898M
Total Liabilities $6.089M $6.910M $6.910M
YoY Change -26.96% -4.79% -4.79%
SHAREHOLDERS EQUITY
Retained Earnings $18.04M $18.30M
YoY Change -9.53% 83.04%
Common Stock $13.21M $13.16M
YoY Change 2.72% 3.63%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $31.25M $31.46M $31.46M
YoY Change
Total Liabilities & Shareholders Equity $37.34M $38.37M $38.37M
YoY Change -9.23% 28.09% 28.09%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2023
OPERATING ACTIVITIES
Net Income -$257.6K -$262.6K $8.302M
YoY Change -102.59% -168.11% 554.55%
Depreciation, Depletion And Amortization $45.61K $44.12K $230.3K
YoY Change -32.53% -35.44% -21.53%
Cash From Operating Activities -$713.2K $118.9K $10.74M
YoY Change -106.1% -144.1% -1239.02%
INVESTING ACTIVITIES
Capital Expenditures $312.7K $30.20K $98.44K
YoY Change 2556.23% -398.12% -8.98%
Acquisitions
YoY Change
Other Investing Activities -$80.00K $46.68K -$16.93M
YoY Change -9.08% -982.33%
Cash From Investing Activities -$393.5K $16.48K -$17.02M
YoY Change 294.46% -262.69% -1040.49%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 34.02K 171.4K
YoY Change -100.0% -87.68%
NET CHANGE
Cash From Operating Activities -713.2K 118.9K 10.74M
Cash From Investing Activities -393.5K 16.48K -17.02M
Cash From Financing Activities 0.000 34.02K 171.4K
Net Change In Cash -1.107M 169.4K -6.117M
YoY Change -109.49% -160.56% -370.91%
FREE CASH FLOW
Cash From Operating Activities -$713.2K $118.9K $10.74M
Capital Expenditures $312.7K $30.20K $98.44K
Free Cash Flow -$1.026M $88.72K $10.64M
YoY Change -108.78% -134.19% -1112.4%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0000056701
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2023Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
0-3295
CY2023 dei Entity Registrant Name
EntityRegistrantName
KOSS CORPORATION
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
39-1168275
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
4129 North Port Washington Avenue
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Milwaukee
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
WI
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
53212
CY2023 dei City Area Code
CityAreaCode
414
CY2023 dei Local Phone Number
LocalPhoneNumber
964-5000
CY2023 dei Security12b Title
Security12bTitle
Common Stock, $0.005 par value per share
CY2023 dei Trading Symbol
TradingSymbol
KOSS
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Public Float
EntityPublicFloat
24849955
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9234795
CY2023 dei Auditor Name
AuditorName
Wipfli LLP
CY2023 dei Auditor Firm
AuditorFirmId
344
CY2023 dei Auditor Location
AuditorLocation
Milwaukee, Wisconsin
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3091062
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9208170
CY2023Q2 us-gaap Short Term Investments
ShortTermInvestments
17064274
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6027
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2027
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1379517
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1846620
CY2023Q2 us-gaap Inventory Net
InventoryNet
6423441
CY2022Q2 us-gaap Inventory Net
InventoryNet
8631362
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
284622
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
188478
CY2023Q2 us-gaap Interest Receivable Current
InterestReceivableCurrent
51150
CY2023Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
86901
CY2022Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
3085
CY2023Q2 us-gaap Assets Current
AssetsCurrent
28380967
CY2022Q2 us-gaap Assets Current
AssetsCurrent
19877715
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
953903
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1088017
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3015887
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3247725
CY2023Q2 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
6020048
CY2022Q2 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
5744724
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9035935
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8992449
CY2023Q2 us-gaap Assets
Assets
38370805
CY2022Q2 us-gaap Assets
Assets
29958181
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
267513
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
796163
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
970530
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
560356
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
450312
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
543891
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
236225
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
223530
CY2023Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
87237
CY2022Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
6118
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2011817
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2130058
CY2023Q2 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
1997120
CY2022Q2 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
1937229
CY2023Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
113003
CY2022Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
169210
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2787970
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3024195
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
4898093
CY2022Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
5130634
CY2023Q2 us-gaap Liabilities
Liabilities
6909910
CY2022Q2 us-gaap Liabilities
Liabilities
7260692
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.005
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.005
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9234795
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9234795
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9147795
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9147795
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
46174
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
45739
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
13113993
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
12653402
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
18300728
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
9998348
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
31460895
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
22697489
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
38370805
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29958181
CY2023 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
13099651
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
17705519
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8642237
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10989889
CY2023 us-gaap Gross Profit
GrossProfit
4457414
CY2022 us-gaap Gross Profit
GrossProfit
6715630
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
29358466
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5813607
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-24901052
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
902023
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
33000000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
362390
CY2023 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
520809
CY2022 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
11513
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8619757
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1275926
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
317377
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7517
CY2023 us-gaap Net Income Loss
NetIncomeLoss
8302380
CY2022 us-gaap Net Income Loss
NetIncomeLoss
1268409
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.90
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.85
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9192799
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9070277
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9753760
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9985662
CY2023 us-gaap Net Income Loss
NetIncomeLoss
8302380
CY2022 us-gaap Net Income Loss
NetIncomeLoss
1268409
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4000
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-35305
CY2023 us-gaap Depreciation
Depreciation
230292
CY2022 us-gaap Depreciation
Depreciation
293465
CY2023 koss Amortization Of Discount On Treasury Securities
AmortizationOfDiscountOnTreasurySecurities
-226603
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
8308
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
289676
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
463633
CY2023 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
187329
CY2022 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
211636
CY2023 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
59891
CY2022 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-160120
CY2022 koss Deferred Compensation Arrangement With Individual Distribution Gain
DeferredCompensationArrangementWithIndividualDistributionGain
71250
CY2022 koss Deferred Compensation Arrangement With Individual Relieved
DeferredCompensationArrangementWithIndividualRelieved
472883
CY2022 koss Gain Loss On Life Insurance Proceeds
GainLossOnLifeInsuranceProceeds
262391
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2263
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-7856
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-463103
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-429470
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2207921
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2729850
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
96144
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-267526
CY2023 us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
51150
CY2023 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
83816
CY2023 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
81119
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1510
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-528650
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
397730
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
410174
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
44789
CY2023 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-149786
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-170463
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10735649
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-942530
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
98441
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
108158
CY2023 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
87995
CY2022 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
95887
CY2022 us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
2014184
CY2023 us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
2022000
CY2023 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
18859671
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17024107
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1810139
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
171350
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1390346
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
171350
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1390346
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-6117108
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2257955
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9208170
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6950215
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3091062
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9208170
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
320073
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
19575101
CY2022 us-gaap Net Income Loss
NetIncomeLoss
1268409
CY2022 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
463633
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1390346
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
22697489
CY2023 us-gaap Net Income Loss
NetIncomeLoss
8302380
CY2023 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
289676
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
171350
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
31460895
CY2023Q2 koss Number Of Subsidiaries
NumberOfSubsidiaries
2
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.50
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.30
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P2Y
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.20
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P3Y
CY2023 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
43190
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
571719
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
288231
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
285244
CY2023 us-gaap Advertising Expense
AdvertisingExpense
65374
CY2022 us-gaap Advertising Expense
AdvertisingExpense
50513
CY2022Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
551562
CY2023Q2 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
138665
CY2022Q2 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
176447
CY2023 us-gaap Proceeds From License Fees Received
ProceedsFromLicenseFeesReceived
33000000
CY2022 us-gaap Proceeds From License Fees Received
ProceedsFromLicenseFeesReceived
100000
CY2021Q4 us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
262000
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">USE OF ESTIMATES — The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of revenue and expenses during the reported periods. Actual results could differ from those estimates.</span>
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
8216671
CY2023 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
13099651
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
17705519
CY2023 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
338529
CY2022 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
453693
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
883564
CY2023Q2 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
17064274
CY2023Q2 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
93740
CY2023Q2 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
16970534
CY2022Q2 us-gaap Investments
Investments
0
CY2023Q2 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
17064274
CY2023Q2 us-gaap Held To Maturity Securities Debt Maturities Within One Year Fair Value
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
16970534
CY2023Q2 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
17064274
CY2023Q2 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
16970534
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
2071360
CY2022Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
2217621
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
6178186
CY2022Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
8302546
CY2023Q2 us-gaap Inventory Gross
InventoryGross
8249546
CY2022Q2 us-gaap Inventory Gross
InventoryGross
10520167
CY2023Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1826105
CY2022Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1888805
CY2023Q2 us-gaap Inventory Net
InventoryNet
6423441
CY2022Q2 us-gaap Inventory Net
InventoryNet
8631362
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8779972
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8828654
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7826069
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7740637
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
953903
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1088017
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
9942511
CY2023Q2 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
63855
CY2023Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
169552
CY2022Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
292155
CY2023Q2 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
136294
CY2022Q2 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
122764
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
744431
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
230139
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
87238
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
7517
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
317377
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7517
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
1803000
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
267945
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
323565
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
47765
CY2023 koss Income Tax Reconciliation Utilization Of Net Operating Loss Carryforwards
IncomeTaxReconciliationUtilizationOfNetOperatingLossCarryforwards
1720747
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-44841
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1486001
CY2023 koss Effective Income Tax Rate Reconciliation Deduction Addback Employee Stock Ownership Plan Dividend Amount
EffectiveIncomeTaxRateReconciliationDeductionAddbackEmployeeStockOwnershipPlanDividendAmount
24218
CY2022 koss Effective Income Tax Rate Reconciliation Deduction Addback Employee Stock Ownership Plan Dividend Amount
EffectiveIncomeTaxRateReconciliationDeductionAddbackEmployeeStockOwnershipPlanDividendAmount
1966822
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
127612
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
-41701
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
-50573
CY2023 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
19340
CY2022 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
34936
CY2023 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
-54414
CY2022 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
-38863
CY2022 koss Effective Income Tax Rate Reconciliation Adjustment To Deferred Tax Assets Amount
EffectiveIncomeTaxRateReconciliationAdjustmentToDeferredTaxAssetsAmount
7573
CY2023 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
83094
CY2022 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
157716
CY2023 koss Income Tax Reconciliation Uncertain Tax Position
IncomeTaxReconciliationUncertainTaxPosition
25269
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-12290
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
4099
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
317377
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7517
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits
491608
CY2022Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits
479340
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
117607
CY2022Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
107499
CY2022Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
803603
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9906018
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11671606
CY2023Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
744384
CY2022Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
804275
CY2023Q2 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
742386
CY2022Q2 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
803603
CY2023Q2 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
1998
CY2022Q2 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
672
CY2023Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
31800000
CY2023Q2 koss Uncertain Tax Position Related To Research And Development Costs
UncertainTaxPositionRelatedToResearchAndDevelopmentCosts
25000
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2023 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11671606
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-1765588
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9906018
CY2021Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
10185605
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1486001
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11671606
CY2022 us-gaap Interest Expense Debt
InterestExpenseDebt
0
CY2023 us-gaap Interest Expense Debt
InterestExpenseDebt
0
CY2022Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Forfeitures In Period Exercise Price Lower Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsForfeituresInPeriodExercisePriceLowerLimit
1.73
CY2022Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Forfeitures In Period Exercise Price Upper Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsForfeituresInPeriodExercisePriceUpperLimit
2.65
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.00
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1058911
CY2023Q2 koss Cooperative Advertising And Promotion Allowances
CooperativeAdvertisingAndPromotionAllowances
77181
CY2022Q2 koss Cooperative Advertising And Promotion Allowances
CooperativeAdvertisingAndPromotionAllowances
200175
CY2023Q2 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
281780
CY2022Q2 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
30515
CY2023Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
76323
CY2022Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
75101
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
85500
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
86500
CY2023Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
369529
CY2022Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
91784
CY2023Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
46857
CY2022Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
39195
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
33360
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
37086
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
970530
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
560356
CY2022Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Outstanding Exercise Price Lower Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsOutstandingExercisePriceLowerLimit
1.73
CY2022Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Outstanding Exercise Price Upper Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsOutstandingExercisePriceUpperLimit
2.92
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.18
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y8M19D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
5055797
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
87000
CY2023Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Exercises In Period Exercise Price Lower Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExercisesInPeriodExercisePriceLowerLimit
1.73
CY2023 us-gaap Net Income Loss
NetIncomeLoss
8302380
CY2022 us-gaap Net Income Loss
NetIncomeLoss
1268409
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9192799
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9070277
CY2023 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
560961
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
915385
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9753760
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9985662
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.90
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.85
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
195205
CY2023 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y3M29D
CY2023 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
289676
CY2022 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
463633
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1748000
CY2021Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Outstanding Exercise Price Lower Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsOutstandingExercisePriceLowerLimit
1.73
CY2021Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Outstanding Exercise Price Upper Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsOutstandingExercisePriceUpperLimit
6.00
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.29
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y10M9D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
36594280
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
539089
CY2022Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Exercises In Period Exercise Price Lower Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExercisesInPeriodExercisePriceLowerLimit
1.73
CY2022Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Exercises In Period Exercise Price Upper Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExercisesInPeriodExercisePriceUpperLimit
6.00
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.58
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
150000
CY2023Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Exercises In Period Exercise Price Upper Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExercisesInPeriodExercisePriceUpperLimit
2.65
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.97
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
51000
CY2023Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Forfeitures In Period Exercise Price Lower Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsForfeituresInPeriodExercisePriceLowerLimit
1.73
CY2023Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Forfeitures In Period Exercise Price Upper Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsForfeituresInPeriodExercisePriceUpperLimit
2.65
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.92
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
920911
CY2023Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Outstanding Exercise Price Lower Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsOutstandingExercisePriceLowerLimit
1.73
CY2023Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Outstanding Exercise Price Upper Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsOutstandingExercisePriceUpperLimit
2.92
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.21
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y2M15D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1373117
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
264577
CY2022Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Exercisable Exercise Price Lower Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExercisableExercisePriceLowerLimit
1.73
CY2022Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Exercisable Exercise Price Upper Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExercisableExercisePriceUpperLimit
2.92
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.45
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y21D
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1180591
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
532245
CY2023Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Exercisable Exercise Price Lower Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExercisableExercisePriceLowerLimit
1.73
CY2023Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Exercisable Exercise Price Upper Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExercisableExercisePriceUpperLimit
2.92
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.38
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y3M18D
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
700947
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
371714
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
9032778
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
171350
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1390346
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
448476
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
620018
CY2023 us-gaap Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
77328
CY2022 us-gaap Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
1778981
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
380000
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
380000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
380000
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P10Y
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1460000
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.23
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
515666
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
1.20
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
150000
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
1.38
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
794334
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.22
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
354668
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
1.26
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
51000
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
1.34
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
388666
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.17
CY2023Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2023 koss Lease Extension Per Year
LeaseExtensionPerYear
380000
CY2023Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
387669
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P11Y
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0525
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0525
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
380000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
380000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
380000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
380000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
380000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
1985000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3885000
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
860805
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
3024195
CY2022 us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
0
CY2023 us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
0
CY2022 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.25
CY2023 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.25
CY2023 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
92986
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
89314
CY2023 us-gaap Proceeds From License Fees Received
ProceedsFromLicenseFeesReceived
33000000
CY2023 us-gaap Legal Fees
LegalFees
22141000
CY2022Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
41000
CY2023Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
41000
CY2023Q2 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
41000

Files In Submission

Name View Source Status
0000056701-23-000026-index-headers.html Edgar Link pending
0000056701-23-000026-index.html Edgar Link pending
0000056701-23-000026.txt Edgar Link pending
0000056701-23-000026-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
koss-20230630.xsd Edgar Link pending
koss-20230630x10k.htm Edgar Link pending
koss-20230630xex10_6.htm Edgar Link pending
koss-20230630xex10_6g001.jpg Edgar Link pending
koss-20230630xex10_6g002.jpg Edgar Link pending
koss-20230630xex23_1.htm Edgar Link pending
koss-20230630xex31_1.htm Edgar Link pending
koss-20230630xex31_2.htm Edgar Link pending
koss-20230630xex32_1.htm Edgar Link pending
koss-20230630xex32_2.htm Edgar Link pending
koss-20230630xex9_1.htm Edgar Link pending
koss-20230630xex9_1g001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
koss-20230630_cal.xml Edgar Link unprocessable
koss-20230630_def.xml Edgar Link unprocessable
koss-20230630_lab.xml Edgar Link unprocessable
koss-20230630_pre.xml Edgar Link unprocessable
koss-20230630x10k_htm.xml Edgar Link completed
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending